SCHEMBL20640259

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL20653752	0.82	OPRM1 (0.85)	OPRM1OPRL1
	SCHEMBL20653754	0.82	OPRM1 (0.85)	OPRM1OPRL1
	SCHEMBL20640202	0.82	OPRM1 (0.85)	OPRM1OPRL1
	SCHEMBL22301062	0.79	HDAC6 (0.52)	OPRM1OPRL1HDAC6
	SCHEMBL22823349	0.78	OPRM1 (0.66)	OPRM1OPRL1
	SCHEMBL19094091	0.77	OPRM1 (1.00)	OPRM1OPRL1
	SCHEMBL19094089	0.77	OPRM1 (1.00)	OPRM1OPRL1
	SCHEMBL19104819	0.77	OPRM1 (1.00)	OPRM1OPRL1
	SCHEMBL29460866	0.77	OPRM1 (1.00)	OPRM1OPRL1
	SCHEMBL20389064	0.76	OPRM1 (0.81)	OPRM1OPRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.